A Dispersion Model for Cellular Signal Transduction Cascades

AbstractPurpose. The purpose of this study was to evaluate the ability of the dispersion model to describe pharmacokinetic-pharmacodynamic data containing contributions from signal transduction cascades. Methods. The partial differential equations and appropriate boundary conditions describing the dispersion model for signal transduction were obtained. Explicit analytical solutions to the dispersion equation were not available, and a numerical approach was necessary. Solutions were obtained by numerical inversion of the output Laplace transform. Generalized least square fitting was used to obtain parameter estimates for a variety of experimental data sets. Results. The parameters of the dispersion model estimate the relative roles of diffusion, convection, and chemical reaction in signal transduction. The model is capable of describing messenger RNA and protein expression kinetics induced by drug action. Conclusions. The dispersion model may find potential applications in pharmacokinetic-pharmacodynamic models involving delayed drug effects mediated by transcriptional changes.

[1]  F. H. Schmidt,et al.  The role of mRNA and protein stability in gene expression , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Almerico Murli,et al.  Software for an implementation of Weeks' method for the inverse Laplace transform , 1988, TOMS.

[3]  Almerico Murli,et al.  Algorithm 662: A Fortran software package for the numerical inversion of the Laplace transform based on Weeks' method , 1988, TOMS.

[4]  Richard R. Almon,et al.  Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  Michael S. Roberts,et al.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  M. Rowland,et al.  A Whole-Body Physiologically Based Pharmacokinetic Model Incorporating Dispersion Concepts: Short and Long Time Characteristics , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[7]  F. H. Schmidt,et al.  A computer program for modeling the kinetics of gene expression. , 1990, BioTechniques.

[8]  Varun Garg,et al.  Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  William T. Weeks,et al.  Numerical Inversion of Laplace Transforms Using Laguerre Functions , 1966, JACM.

[10]  M B Hallett,et al.  Stochastic events underlie Ca2+ signalling in neutrophils. , 1997, Journal of theoretical biology.

[11]  I. Branehög Platelet Kinetics in Idiopathic Thrombocytopenic Purpura (ITP) before and at Different Times after Splenectomy , 1975, British journal of haematology.

[12]  M. Rowland,et al.  Hepatic elimination--dispersion model. , 1985, Journal of pharmaceutical sciences.

[13]  W J Jusko,et al.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. , 1998, Journal of pharmaceutical sciences.

[14]  L. Fan,et al.  Models for flow systems and chemical reactors , 1975 .

[15]  Y. Sugiyama,et al.  Analysis of Nonlinear and Nonsteady State Hepatic Extraction with the Dispersion Model Using the Finite Difference Method , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  James N. Lyness,et al.  Remark on algorithm 662 , 1990, TOMS.

[17]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.